Gujarat Terce Laboratories Ltd - Shs Dematerialised

BOM:524314 (India)   Shs Dematerialised
₹ 55.95 (+1.99%) May 24
81.09
P/B:
7.06
Market Cap:
₹ 415.17M ($ 5.00M)
Enterprise V:
₹ 458.81M ($ 5.52M)
Volume:
1.67K
Avg Vol (2M):
19.71K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Gujarat Terce Laboratories Ltd ( BOM:524314 ) from 1994 to May 25 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Gujarat Terce Laboratories stock (BOM:524314) PE ratio as of May 25 2024 is 81.09. More Details

Gujarat Terce Laboratories Ltd (BOM:524314) PE Ratio (TTM) Chart

To

Gujarat Terce Laboratories Ltd (BOM:524314) PE Ratio (TTM) Historical Data

Total 1230
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Gujarat Terce Laboratories PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-25 81.1 2024-03-14 51.2
2024-05-24 81.1 2024-03-13 48.8
2024-05-23 79.5 2024-03-12 51.3
2024-05-22 80.9 2024-03-11 49.0
2024-05-21 82.6 2024-03-07 51.6
2024-05-17 84.1 2024-03-06 49.3
2024-05-16 85.5 2024-03-05 51.9
2024-05-15 87.3 2024-03-04 49.5
2024-05-14 89.1 2024-03-01 47.1
2024-05-13 90.9 2024-02-29 49.1
2024-05-10 89.1 2024-02-28 47.1
2024-05-09 90.9 2024-02-27 49.2
2024-05-08 92.8 2024-02-26 46.8
2024-05-07 94.7 2024-02-23 45.2
2024-05-06 96.6 2024-02-22 47.2
2024-05-03 98.5 2024-02-21 45.0
2024-05-02 98.5 2024-02-20 45.3
2024-04-30 97.7 2024-02-19 46.7
2024-04-29 95.8 2024-02-16 45.9
2024-04-26 93.9 2024-02-15 43.8
2024-04-25 95.8 2024-02-14 44.4
2024-04-24 97.8 2024-02-13 42.3
2024-04-23 99.7 2024-02-12 41.2
2024-04-22 101.8 2024-02-09 43.4
2024-04-19 96.9 2024-02-08 43.4
2024-04-18 92.3 2024-02-07 43.4
2024-04-16 87.9 2024-02-06 43.4
2024-04-15 83.8 2024-02-05 43.4
2024-04-12 79.8 2024-02-02 45.6
2024-04-10 84.0 2024-02-01 45.6
2024-04-09 88.4 2024-01-31 45.6
2024-04-08 93.0 2024-01-30 45.6
2024-04-05 97.9 2024-01-29 45.6
2024-04-04 93.2 2024-01-26 48.0
2024-04-03 88.8 2024-01-25 48.0
2024-04-02 84.6 2024-01-24 48.0
2024-04-01 80.6 2024-01-23 48.0
2024-03-28 76.7 2024-01-22 50.6
2024-03-27 73.1 2024-01-19 50.6
2024-03-26 69.6 2024-01-18 50.6
2024-03-22 66.3 2024-01-17 50.6
2024-03-21 63.2 2024-01-16 50.6
2024-03-20 60.2 2024-01-15 50.6
2024-03-19 57.3 2024-01-12 50.6
2024-03-18 55.1 2024-01-11 51.7

Gujarat Terce Laboratories Ltd (BOM:524314) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Gujarat Terce Laboratories Ltd is an India company having business in the medical and pharmaceutical preparations. It is engaged in the manufacturing of tablets, capsules, and syrup and injection. It offers branded as well as generic formulations covering different therapeutic areas such as antibiotics, respiratory, nutraceuticals, gastrointestinal, anti-fungal, and many more. Some of the main brands are Acolate, Tynol, DFS, Resplash , Aziter and others.